Patent Assignment
Reel/Frame 069894/0985
Intellectual Property Security Agreement
Recorded: 2025-01-14
Pages: 9
Assignor
BAUSCH HEALTH IRELAND LIMITED
Executed: 2025-01-10
Assignee
THE BANK OF NEW YORK MELLON
240 GREENWICH STREET, NEW YORK, NEW YORK, 10286
Covered Properties
(2)
Amiselimod for Preventing, Treating or Ameliorating Ulcerative Colitis
Application:
18/276,120 →
Publication:
US 2024/0299318
Topical Compositions and Methods for Treating Skin Diseases
Application:
18/896,188 →
Publication:
US 2025/0017854
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Intellectual Property Security Agreement
Jan 14, 2025
From: BAUSCH HEALTH IRELAND LIMITED
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 069894/0976 →
Second Lien Intellectual Property Security Agreement
Jan 14, 2025
From: BAUSCH HEALTH IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 069895/0015 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
U.S. Patent Security Agreement
Nov 25, 2025
From: BAUSCH HEALTH IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 073715/0375 →
Assignment of Assignor's Interest
Aug 4, 2026
From: LEE, JIMIN; SLATKIN, NEAL; LOWE, EZRA R.
To: BAUSCH HEALTH US, LLC
Reel/Frame 075513/0291 →
Assignment of Assignor's Interest
Aug 4, 2026
From: BAUSCH HEALTH US, LLC
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 075513/0497 →